These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29934621)

  • 21. Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysis.
    Grenet G; Le HH; Bejan-Angoulvant T; Erpeldinger S; Boussageon R; Kassaï B; Moulin P; Gueyffier F; Cucherat M
    Diabetes Metab; 2019 Dec; 45(6):550-556. PubMed ID: 31150802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contemporary Drug Treatment of Hypertension: Focus on Recent Guidelines.
    Aronow WS; Frishman WH
    Drugs; 2018 Apr; 78(5):567-576. PubMed ID: 29536372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should blood pressure goal be individualized in hypertensive patients?
    Yannoutsos A; Kheder-Elfekih R; Halimi JM; Safar ME; Blacher J
    Pharmacol Res; 2017 Apr; 118():53-63. PubMed ID: 27919826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management plans for populations with normal-to-hypertensive blood pressures: risks and benefits of antihypertensive drug treatment in populations previously defined as having high-normal blood pressure.
    Park S
    Korean J Intern Med; 2019 Jan; 34(1):44-49. PubMed ID: 30612417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockers.
    Kalaitzidis R; Bakris G
    Diabetes Obes Metab; 2009 Aug; 11(8):757-69. PubMed ID: 19519867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Which Target Blood Pressure in Year 2018? Evidence from Recent Clinical Trials.
    Heimark S; Mariampillai JE; Narkiewicz K; Nilsson PM; Kjeldsen SE
    High Blood Press Cardiovasc Prev; 2018 Jun; 25(2):151-158. PubMed ID: 29663195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: rationale, design, and methods.
    Fukui T; Rahman M; Hayashi K; Takeda K; Higaki J; Sato T; Fukushima M; Sakamoto J; Morita S; Ogihara T; Fukiyama K; Fujishima M; Saruta T;
    Hypertens Res; 2003 Dec; 26(12):979-90. PubMed ID: 14717341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between blood pressure and kidney diseases in large randomized controlled trials: secondary analyses using SPRINT and ACCORD-BP trials.
    Wang L; Pezeshkian K; Rayamajhi S; Herzallah K; Al-Abcha A; Olomu A; Kelly-Blake K; Yu E; Wang DH
    J Hum Hypertens; 2021 Oct; 35(10):859-869. PubMed ID: 33093616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.
    Bangalore S; Kumar S; Lobach I; Messerli FH
    Circulation; 2011 Jun; 123(24):2799-810, 9 p following 810. PubMed ID: 21632497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
    Tandon N; Ali MK; Narayan KM
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of mineralocorticoid receptor antagonists in patients with hypertension and diabetes mellitus: a systematic review and meta-analysis.
    Takahashi S; Katada J; Daida H; Kitamura F; Yokoyama K
    J Hum Hypertens; 2016 Sep; 30(9):534-42. PubMed ID: 26674759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?
    Bhatt H; Ghazi L; Calhoun D; Oparil S
    Curr Cardiol Rep; 2016 Oct; 18(10):98. PubMed ID: 27566331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension.
    Chiang CE; Wang TD; Li YH; Lin TH; Chien KL; Yeh HI; Shyu KG; Tsai WC; Chao TH; Hwang JJ; Chiang FT; Chen JH;
    J Formos Med Assoc; 2010 Oct; 109(10):740-73. PubMed ID: 20970072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study.
    Karpov YA;
    Clin Drug Investig; 2017 Feb; 37(2):207-217. PubMed ID: 27878562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial.
    Petrie JR; Marso SP; Bain SC; Franek E; Jacob S; Masmiquel L; Leiter LA; Haluzik M; Satman I; Omar M; Shestakova M; Van Gaal L; Mann JF; Baeres FM; Zinman B; Poulter NR;
    J Hypertens; 2016 Jun; 34(6):1140-50. PubMed ID: 26855018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk.
    Olsen E; Holzhauer B; Julius S; Kjeldsen SE; Larstorp ACK; Mancia G; Mehlum MH; Mo R; Rostrup M; Søraas CL; Zappe D; Weber MA
    Blood Press; 2021 Apr; 30(2):90-97. PubMed ID: 33403890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should we change the target blood pressure in diabetic patients?
    Shlomai G; Grossman E
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():1-7. PubMed ID: 23280860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing Heart Failure by Treating Systolic Hypertension: What Does the SPRINT Add?
    Upadhya B; Stacey RB; Kitzman DW
    Curr Hypertens Rep; 2019 Jan; 21(1):9. PubMed ID: 30659372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pros and cons of aggressive blood pressure lowering in patients with type 2 diabetes.
    Kalaitzidis RG; Bakris GL
    Curr Vasc Pharmacol; 2012 Mar; 10(2):156-61. PubMed ID: 22239626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.
    Ramsay L; Williams B; Johnston G; MacGregor G; Poston L; Potter J; Poulter N; Russell G
    J Hum Hypertens; 1999 Sep; 13(9):569-92. PubMed ID: 10482967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.